Announcements Trials

Browse Landscape

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Adenocarcinoma 1

Interventions

pembrolizumab 26 Cisplatin 14 Nivolumab 11 Cyclophosphamide 11 Carboplatin 11 Paclitaxel 9 Docetaxel 9 Radiotherapy, Intensity-Modulated 8 Radiotherapy 8 Magnetic Resonance Spectroscopy 8 Radiosurgery 7 Radiation 7 Fluorouracil 7 Bevacizumab 7 Leucovorin 6 Irinotecan 6 Gemcitabine 6 Doxorubicin 6 venetoclax 5 olaparib 5 enzalutamide 5 Prednisone 5 Pemetrexed 5 Oxaliplatin 5 Metformin 5 Azacitidine 5 fludarabine 4 atezolizumab 4 Taxes 4 Surveys and Questionnaires 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × paricalcitol × 30 days × Clear all

NCT03415854 2026-05-12

NABPLAGEMD

HonorHealth Research Institute

Phase 2 Completed

34 enrolled 11 charts

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡